ESMO Annual Meeting 2017 Presentation

Impact of Prior Treatment on Palbociclib Plus Letrozole Efficacy and Safety in Patients with Estrogen Receptor-Postivie/Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) First-Line Advanced Breast Cancer: a PALOMA-2 Subgroup Analysis